Esperion Therapeutics, Inc. (LON:0IIM)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.7862
-0.1139 (-12.65%)
At close: May 9, 2025

Esperion Therapeutics Market Cap

Esperion Therapeutics has a market cap or net worth of 118.97 million as of May 9, 2025. Its market cap has decreased by -63.34% in one year.

Market Cap
118.97M
Enterprise Value
479.48M
Revenue
200.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.79

Market Cap Chart

Since June 26, 2013, Esperion Therapeutics's market cap has decreased from 137.93M to 118.97M, a decrease of -13.74%. That is a compound annual growth rate of -1.24%.

History

DateMarket Cap% Change
May 9, 2025118.97M-65.64%
Dec 31, 2024346.25M29.71%
Dec 29, 2023266.94M-29.93%
Dec 30, 2022380.99M68.53%
Dec 31, 2021226.06M-57.42%
Dec 31, 2020530.87M-56.85%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 158.79B
GSK plc 55.98B
Haleon 36.67B
Smith & Nephew 9.35B
ConvaTec Group 5.26B
Hikma Pharmaceuticals 4.42B
HUTCHMED (China) 1.95B
Genus 1.39B
Market Cap Rankings